Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study-Reference-Cited by-同舟云学术

Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study

Published:2008-06 Issue:9630 Volume:371 Page:2101-2108
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Spano Jean-Philippe,Chodkiewicz Catherine,Maurel Joan,Wong Ralph,Wasan Harpreet,Barone Carlo,Létourneau Richard,Bajetta Emilio,Pithavala Yazdi,Bycott Paul,Trask Peter,Liau Katherine,Ricart Alejandro D,Kim Sinil,Rixe Olivier

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

3. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J Clin Oncol,1997

4. Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297;Berlin;J Clin Oncol,2002

5. Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate;Rocha Lima;J Clin Oncol,2004

Cited by 233 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiogenesis and Pancreatic Cancer: Novel Approaches to Overcome Treatment Resistance;Current Cancer Drug Targets;2024-11

2. Effect of PAWI-2 on pancreatic cancer stem cell tumors;Investigational New Drugs;2024-05-25

3. Theoretical investigation of fullerene (C60) as nano carrier for anti-cancer drug Axitinib;Carbon Trends;2024-03

4. Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata;British Journal of Cancer;2023-09-08

5. Recent advances in targeted therapy for pancreatic adenocarcinoma;World Journal of Gastrointestinal Oncology;2023-04-15